Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: implications for FXIII therapy and antithrombin use in myocardial infarction.
about
Modulators of Macrophage Polarization Influence Healing of the Infarcted MyocardiumMolecular Imaging of Healing After Myocardial Infarction.Multimodality cardiovascular molecular imaging, Part IIMolecular imaging in cardiovascular disease: Which methods, which diseases?Cardiovascular molecular imaging: focus on clinical translationFactor XIII-A Val34Leu polymorphism might beassociated with myocardial infarction risk: an updated meta-analysis.Molecular imaging of coronary atherosclerosis and myocardial infarction: considerations for the bench and perspectives for the clinicSystematic characterization of myocardial inflammation, repair, and remodeling in a mouse model of reperfused myocardial infarction.Post-infarct remodelling: contribution of wound healing and inflammation.New molecular imaging targets to characterize myocardial biology.Advances in radionuclide molecular imaging in myocardial biology.Ischemia/Reperfusion Injury following Acute Myocardial Infarction: A Critical Issue for Clinicians and Forensic Pathologists.Factor XIII: a coagulation factor with multiple plasmatic and cellular functions.Contrast-enhanced MRI of murine myocardial infarction - part I.Advances in molecular imaging of atherosclerosis and myocardial infarction: shedding new light on in vivo cardiovascular biology.New developments in the area of factor XIII.The hemostatic system as a regulator of inflammation in atherosclerosis.Bioresponsive probes for molecular imaging: concepts and in vivo applications.Newly-Recognized Roles of Factor XIII in Thrombosis.Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot.Factor XIII Subunit A in the Skin: Applications in Diagnosis and Treatment.Fibrosis imaging: Current concepts and future directions.Molecular imaging of myocardial infarction.Effect of factor XIII-A Val34Leu polymorphism on myocardial infarction risk: a meta-analysis.Coagulation factor XIII-A Val34Leu polymorphism and the risk of coronary artery disease and myocardial infarction in a Chinese Han population.The year in molecular imaging.Mapping macrophage polarization over the myocardial infarction time continuum.MRI of inducible P-selectin expression in human activated platelets involved in the early stages of atherosclerosisGene Variant (V34L) and Residual Circulating FXIIIA Levels Predict Short- and Long-Term Mortality in Acute Myocardial Infarction after Coronary AngioplastyFibrinogen and factor XIII: newly recognized roles in venous thrombus formation and composition
P2860
Q26774265-E5CC19B0-0C55-4205-94FC-D7E9E0E885A6Q30428495-A16667D1-3CC7-44DD-AA56-222C3E9FCBF3Q30438207-0422CF76-702A-4270-9A3A-EA2961FB66F8Q30442045-ACF5D0F7-F224-4319-B995-0492A4F0AF44Q30470859-EB6641C5-0C9F-4969-BB08-989977CE7C89Q35017271-542C923C-7B11-41CD-9A36-7EA8C4B7F80DQ36095916-0C768C42-9628-4C3C-B308-1616EC9C462AQ37047650-D87E8B98-3A68-44C3-9BDD-D3602478084BQ37314909-5EA4F699-0870-4C21-85E8-19BDA1E20552Q37420825-144FDBBE-B633-4739-A81A-E9FB6880FB31Q37655420-179D4C93-B2B0-4093-BC0C-6A923847F105Q37668843-0FBFA2EB-7CB7-4694-8007-905533781B14Q37899674-951203FF-000D-4CCA-BD9E-79858826FB02Q37981643-346A91F8-3128-4207-B08A-F73A2C93FF1FQ38052020-7240CDAB-6DCF-4AB4-86FB-FA1CBA50B666Q38070913-B66631A4-BA59-4DCF-8886-3DEB6EB53ED7Q38285796-77C4AF97-588B-4623-A34B-32B89AAD7C5DQ38420827-BE31AF21-FDA2-4BA7-8A01-36A563A63347Q38801273-728503F1-DF04-4683-AED2-8C89B66B4E48Q41825512-D9A2F6A2-6509-4020-8807-79F2911C773DQ47171880-5F2777ED-0B9E-4887-B42D-5AA906A0BA94Q47376188-0ECA4074-820B-4AE6-8DDD-EA536F01C09AQ53079346-14E6E76B-FF0F-43F0-B62E-69004E292B26Q53126490-76D774E7-E440-47AC-B519-BE72187E9776Q54438122-EAFB39EE-EDF5-4C0C-93CB-A76F1CAF25F5Q54911978-D31DEFCA-AE50-4B04-9298-D22F66EC35C7Q55234249-4D28365D-82CC-497E-B599-B540BAE8B8AFQ57185167-F6E89020-2787-442B-8878-A86B16B17392Q58738494-BCD7CA00-E89E-447B-A1FF-03A973819D0BQ58770454-C6F544EA-B519-4E1E-9146-C08508EFAFA3
P2860
Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: implications for FXIII therapy and antithrombin use in myocardial infarction.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Transglutaminase activity in a ...... use in myocardial infarction.
@en
Transglutaminase activity in a ...... use in myocardial infarction.
@nl
type
label
Transglutaminase activity in a ...... use in myocardial infarction.
@en
Transglutaminase activity in a ...... use in myocardial infarction.
@nl
prefLabel
Transglutaminase activity in a ...... use in myocardial infarction.
@en
Transglutaminase activity in a ...... use in myocardial infarction.
@nl
P2093
P2860
P50
P356
P1476
Transglutaminase activity in a ...... n use in myocardial infarction
@en
P2093
David E Sosnovik
Jose-Luiz Figueiredo
Lars Stangenberg
Matthias Nahrendorf
Susanne W van den Borne
W Matthijs Blankesteijn
P2860
P304
P356
10.1093/EURHEARTJ/EHM558
P577
2008-02-01T00:00:00Z